Technology Portfolio Management (TPM) Best Practices

Overview

The health and strategic direction of a technology vendor are material inputs to the technology assessment for every commercially-supplied technology in the portfolio. A vendor that is financially distressed, under acquisition pressure, or shifting its commercial model away from the product the organization depends on creates risk that a technical assessment of the product alone cannot reveal. Vendor health assessment is therefore a required component of the full technology assessment, not an optional supplementary check conducted only when a vendor makes headlines.

Best Practice

Assess technology vendor health on a defined cadence — annually as part of the technology assessment cycle and event-driven whenever a significant vendor development warrants an interim assessment — across the following dimensions. Financial stability: the vendor’s financial health as evidenced by publicly available financial reporting for public companies or by available financial signals for private companies, including investment activity, funding rounds, and any financial distress indicators. Ownership and acquisition status: whether the vendor is under current acquisition pressure, has recently been acquired, or is in a market segment experiencing consolidation that may affect its independence and commercial model. Product roadmap alignment: whether the vendor’s published product roadmap for the technology aligns with the organization’s architectural direction and strategic requirements, and whether the vendor is investing in the capabilities the organization needs or de-emphasizing them in favor of capabilities the organization does not require. Commercial model stability: whether the vendor’s pricing and commercial model is stable and predictable or has recently changed or is showing signs of change that would affect the organization’s total cost of technology for that vendor’s products. Support quality trajectory: whether the vendor’s support quality is improving, stable, or deteriorating, and whether the organization has experienced support quality changes that signal a vendor de-emphasizing investment in the products the organization depends on.

Benefit(s)

Regular vendor health assessment gives the organization early warning of vendor risk before it materializes as a supply disruption, an unexpected price increase, a product end-of-life announcement, or an acquisition that changes the commercial terms and strategic direction of a technology the organization depends on. Organizations that monitor vendor health continuously and update their technology Strategic Dispositions in response to vendor health signals consistently execute technology migrations with more lead time, better alternatives analysis, and lower transition cost than organizations that discover vendor risk only when the risk event has already occurred.